Suppr超能文献

[与Nav1.7突变相关的神经性疼痛:临床表现与治疗]

[Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].

作者信息

Doppler K, Sommer C

机构信息

Neurologische Klinik und Poliklinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland.

出版信息

Nervenarzt. 2013 Dec;84(12):1428-35. doi: 10.1007/s00115-012-3621-7.

Abstract

Voltage-gated sodium channels are essential for electrogenesis in excitable cells. The isoform Nav1.7 is primarily expressed in nociceptors. Mutations of the SCN9A gene, which codes for the α-subunit of Nav1.7, are the cause of primary erythromelalgia and paroxysmal extreme pain disorder, two rare neuropathic pain conditions. Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain. These findings not only contribute to the understanding of the pathophysiology of neuropathic pain but also offer targets for a more specific pain therapy.

摘要

电压门控钠通道对于可兴奋细胞的电活动产生至关重要。Nav1.7亚型主要在伤害感受器中表达。编码Nav1.7α亚基的SCN9A基因突变是原发性红斑性肢痛症和阵发性剧痛障碍这两种罕见神经病理性疼痛病症的病因。最近的研究表明,SCN9A基因突变是特发性小纤维神经病变亚组的病因,并且SCN9A基因多态性与疼痛易感性增加有关。这些发现不仅有助于理解神经病理性疼痛的病理生理学,还为更具特异性的疼痛治疗提供了靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验